AKT3 and melanoma: Recently [77], a nanoliposomal-ultrasound-mediated approach reported for delivering small interfering RNA (siRNA) specifically targeting (V600E)B-Raf and Akt3 into melanocytic tumors present in skin to retard melanoma development.